NYSE: CAH
CARDINAL HEALTH INCCIK 0000721371 · SIC 5122 · Drugs & Sundries
8-Ks, initial S-1s, and selected mega-cap 10-Ks and 10-Qs are open in full. Other reports show a 3-bullet preview; a free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HGIT 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade CAH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-K filed Aug 11, 2026 (period ending Jun 30, 2026). SEC XBRL (companyfacts) — not generated by the model.
Consolidated Statements of Operations
| Description | Year ended Jun 30, 2026 | Year ended Jun 30, 2025 | Year ended Jun 30, 2024 |
|---|---|---|---|
| Revenue: | |||
| Total revenue / net sales | 254,248 | 222,578 | 226,827 |
| Cost of revenue / cost of sales | 244,474 | 214,410 | 219,413 |
| Gross profit | 9,774 | 8,168 | 7,414 |
| Operating expenses: | |||
| Selling, general and administrative | 6,132 | 5,382 | 5,000 |
| Other operating expenses, net | 1,029 | 511.0 | 1,171 |
| Operating income | 2,613 | 2,275 | 1,243 |
| Interest expense | 348.0 | 215.0 | 51.0 |
| Other income/(expense), net | 31.0 | 41.0 | 9.0 |
| Income before income taxes | 2,174 | 2,101 | 1,201 |
| Income tax expense/(benefit) | 469.0 | 532.0 | 348.0 |
| Net income | 1,714 | 1,561 | 852.0 |
| Basic earnings per share | 7.27 | 6.48 | 3.48 |
| Diluted earnings per share | 7.23 | 6.45 | 3.45 |
Consolidated Balance Sheets
| Description | Jun 30, 2026 | Jun 30, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and equivalents | 4,856 | 3,874 |
| Inventories | 17,297 | 16,831 |
| Prepaid expenses and other current assets | 2,764 | 2,414 |
| Other current assets | 13,836 | 13,254 |
| Total current assets | 38,753 | 36,373 |
| Property, plant and equipment, net | 3,031 | 2,858 |
| Operating lease right-of-use assets, net | 991.0 | 758.0 |
| Finite-lived intangible assets, net | 2,165 | 2,473 |
| Identifiable intangible assets, net | 2,189 | 2,486 |
| Goodwill | 11,442 | 9,691 |
| Deferred income taxes and other assets | 63.0 | 64.0 |
| Other long-term assets | (1,335) | (1,581) |
| TOTAL ASSETS | 57,299 | 53,122 |
| Current liabilities: | ||
| Current portion of long-term debt | 1,882 | 550.0 |
| Accounts payable | 38,283 | 34,713 |
| Current portion of operating lease liabilities | 201.0 | 164.0 |
| Other current liabilities | 3,538 | 3,470 |
| Total current liabilities | 43,904 | 38,897 |
| Long-term debt | 7,004 | 7,977 |
| Operating lease liabilities | 861.0 | 654.0 |
| Shareholders' equity: | ||
| Common stock | 2,887 | 2,956 |
| Accumulated other comprehensive income (loss) | (165.0) | (155.0) |
| Retained earnings (deficit) | 2,009 | 783.0 |
| Treasury stock | 7,614 | 6,365 |
| Total shareholders' equity | (2,883) | (2,781) |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 57,299 | 53,122 |
Consolidated Statements of Cash Flows
| Description | Year ended Jun 30, 2026 | Year ended Jun 30, 2025 |
|---|---|---|
| Operating Activities: | ||
| Net cash from operating activities | 5,174 | 2,397 |
| Investing Activities: | ||
| Net cash from investing activities | (2,584) | (5,593) |
| Financing Activities: | ||
| Net cash from financing activities | (1,602) | 1,940 |
| Net increase/(decrease) in cash | 982.0 | (1,259) |
Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗